Literature DB >> 130382

Plasma adrenal and gonadal sex steroids in human pubertal development.

J R Ducharme, M G Forest, E De Peretti, M Sempé, R Collu, J Bertrand.   

Abstract

Plasma free dehydroepiandrosterone (DHA), androstenedione (delta), testosterone (T), dihydrotestosterone (DHT), estrone (E1), and estradiol (E2) were measured by radioimmunoassay in 55 boys and 54 girls 3.5 to 16.3 years of age. Plasma DHA increased significantly between 6 and 8 years of age in girls and between 8 and 10 years of age in boys. A further significant increase was noted between 10 and 12 years of age in both sexes. Delta rose significantly between 8 and 10 years of age in girls and between 10 and 12 years in boys. In contrast, no significant increase in T, DHT, or E1, was noted prior to 12 years of age in both sexes. However, E2 showed a significant increase between 10 and 12 years of age in girls. This early rise in the course of pubertal development of the two sex steroids predominantly of adrenal origin, DHA and delta, and its occurence 1 to 2 years earlier in girls than in boys, as does puberty itself, suggest a possible role for these steroids in the mechanisms involved in triggering the hypothalamic-pituitary-gonadal axis at puberty.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 130382     DOI: 10.1210/jcem-42-3-468

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  39 in total

1.  Hormone changes in peripubertal girls.

Authors:  Frank M Biro; Susan M Pinney; Bin Huang; Erin R Baker; Donald Walt Chandler; Lorah D Dorn
Journal:  J Clin Endocrinol Metab       Date:  2014-07-16       Impact factor: 5.958

2.  Impact of Pubertal Maturation and Chronologic Age on Sex Steroids in Peripubertal Girls.

Authors:  Frank M Biro; Bin Huang; Donald Walt Chandler; Cecily L Fassler; Susan M Pinney
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

3.  11-Ketotestosterone Is the Dominant Circulating Bioactive Androgen During Normal and Premature Adrenarche.

Authors:  Juilee Rege; Adina F Turcu; Josephine Z Kasa-Vubu; Antonio M Lerario; Gabriela C Auchus; Richard J Auchus; Joshua M Smith; Perrin C White; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2018-12-01       Impact factor: 5.958

4.  Adrenal and gonadal steroids and pituitary response to LHRH in girls. II. Precocious puberty.

Authors:  C Pintor; A R Genazzani; P Ibba; L Pecciarini-Snickars; R Corda
Journal:  J Endocrinol Invest       Date:  1978-04       Impact factor: 4.256

Review 5.  The role of gonadotrophin releasing hormone in the investigation and treatment of hypogonadism.

Authors:  A Gossage; S Duncan
Journal:  Postgrad Med J       Date:  1985-03       Impact factor: 2.401

6.  Influence of small doses of dehydroepiandrosterone on the inception of the hormonal function of testes of sexually immature monkeys.

Authors:  N P Goncharov
Journal:  Neurosci Behav Physiol       Date:  1995 Jul-Aug

Review 7.  Steroid biomarkers in human adrenal disease.

Authors:  Juilee Rege; Adina F Turcu; Tobias Else; Richard J Auchus; William E Rainey
Journal:  J Steroid Biochem Mol Biol       Date:  2019-01-29       Impact factor: 4.292

8.  Age-dependent Increases in Adrenal Cytochrome b5 and Serum 5-Androstenediol-3-sulfate.

Authors:  Juilee Rege; Shigehiro Karashima; Antonio M Lerario; Joshua M Smith; Richard J Auchus; Josephine Z Kasa-Vubu; Hironobu Sasano; Yasuhiro Nakamura; Perrin C White; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2016-09-13       Impact factor: 5.958

9.  The developmental changes in plasma adrenal androgens during infancy and adrenarche are associated with changing activities of adrenal microsomal 17-hydroxylase and 17,20-desmolase.

Authors:  R J Schiebinger; B D Albertson; F G Cassorla; D W Bowyer; G W Geelhoed; G B Cutler; D L Loriaux
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

10.  Glucose tolerance and insulin release in adolescent female.

Authors:  L Benassi; G Tridenti; N Orlandi; A Pezzarossa
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.